
News|Articles|July 1, 2004
Key issues emerge surrounding pharmaceutical pricing: Consumer groups and politicians keep a close watch on drug prices and discounts, and on PBM Medicare pharmacy cards
Medicare officials predict that beneficiaries will realize more substantial savings as sponsors drop their prices even more.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
FDA issues draft guidance on MRD and complete response as primary endpoints for accelerated multiple myeloma drug approvals
3
TrumpRx launches; some experts question its long-term value
4
Cancer survival fell and deaths rose during first two years of COVID-19
5























